Myasthenia crisis following percutaneous coronary intervention in a patient with late onset myasthenia gravis: successful treatment of a unique case

2013 ◽  
Vol 28 (3) ◽  
pp. 279-281
Author(s):  
Soumya Patra ◽  
Ajit Pal Singh ◽  
B. C. Srinivas ◽  
C. N. Manjunath
2021 ◽  
Vol 9 (1) ◽  
pp. 9
Author(s):  
Francesca Mantovani ◽  
Alessandro Navazio ◽  
Giovanni Tortorella ◽  
Vincenzo Guiducci

Among pregnant women, SCAD is the most frequent etiology of non-atherosclerotic acute coronary syndrome. SCAD related to pregnancy is more frequent within the first month (especially first week) of puerperium or last trimester, or is otherwise anecdotal. The concomitance of SCAD and pregnancy poses many issues regarding diagnosis and treatment in respect to maternal and fetal safety and requires tailored intervention with close interaction between clinical cardiologists, interventional cardiologists, cardiothoracic surgeons, and obstetricians. We report the case of a patient, pregnant in the second trimester with a life-threatening SCAD, successfully treated with percutaneous coronary intervention with excellent outcome for mother and baby.


2021 ◽  
Author(s):  
Matthew Lavoie ◽  
Ariana Ramirez ◽  
Jeffrey Kunz

ABSTRACT We report the case of a 52-year-old white male who was recently diagnosed with symptomatic coronavirus disease-2019 (COVID-19) and presented to the hospital with ventricular tachycardia/ventricular fibrillation cardiac arrest, ST elevation myocardial infarction, and profound hypokalemia. The patient was successfully treated with primary percutaneous coronary intervention and concurrent aggressive potassium repletion. To the authors’ knowledge, this is the first case of COVID-19 presenting not only with an acute coronary thrombosis but also severe hypokalemia, both of which contributed to his cardiac arrest. The association of COVID-19 with acute coronary thrombosis, including the challenges surrounding the diagnosis and management in this patient population, is discussed. Additionally, the effect of COVID-19 on the renin–angiotensin–aldosterone system is reviewed with a focus on hypokalemic presentations.


Sign in / Sign up

Export Citation Format

Share Document